Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Abstract

Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons.

G Engberg, T Elebring and H Nissbrandt
Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 841-847;
G Engberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T Elebring
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H Nissbrandt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 259 no. 2 841-847
PubMed 
1658311

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online November 1, 1991.


Author Information

  1. G Engberg,
  2. T Elebring and
  3. H Nissbrandt
  1. Department of Pharmacology, University of Göteborg, Sweden.

    Statistics from Altmetric.com

    Article usage

    Article usage: May 1999 to January 2021

    AbstractFullPdf
    May 1999100
    Sep 1999100
    Jun 2000100
    Sep 2000200
    Nov 2000100
    May 2001200
    Jun 2001100
    Jul 2001100
    Sep 2001300
    Jan 2002100
    Mar 2002100
    May 2002200
    Jul 2002100
    Sep 2002100
    Jan 2003200
    Mar 2003200
    Jun 2003200
    Jul 2003200
    Aug 2003200
    Sep 2003500
    Oct 2003800
    Nov 2003600
    Dec 2003500
    Jan 2004700
    Feb 2004500
    Mar 2004500
    Apr 20041200
    May 20041200
    Jun 20041100
    Jul 2004900
    Aug 20041300
    Sep 20041500
    Oct 2004900
    Nov 20041400
    Dec 20041500
    Jan 20052000
    Feb 20051300
    Mar 20052800
    Apr 2005200
    May 2005400
    Jun 2005400
    Aug 2005500
    Sep 2005500
    Oct 2005900
    Nov 2005800
    Dec 20051100
    Jan 2006900
    Feb 2006200
    Mar 2006800
    Apr 2006600
    May 2006603
    Jun 2006801
    Jul 2006701
    Aug 2006200
    Sep 2006301
    Oct 20061000
    Nov 2006703
    Dec 2006401
    Jan 2007400
    Feb 2007300
    Mar 20071202
    Apr 20071101
    May 2007400
    Jun 2007201
    Jul 2007701
    Aug 2007500
    Sep 2007601
    Oct 2007506
    Nov 2007403
    Dec 2007800
    Jan 2008600
    Feb 2008503
    Mar 20081000
    Apr 20081907
    May 20081507
    Jun 20081705
    Jul 20081804
    Aug 2008900
    Sep 20081000
    Oct 2008901
    Nov 20081101
    Dec 20081203
    Jan 20091303
    Feb 20091901
    Mar 20092504
    Apr 20091403
    May 20092102
    Jun 2009901
    Jul 2009800
    Aug 2009702
    Sep 20091302
    Oct 20092601
    Nov 20091003
    Dec 20092102
    Jan 20101804
    Feb 20101200
    Mar 20102205
    Apr 20101201
    May 20102204
    Jun 20101605
    Jul 20102102
    Aug 20102400
    Sep 20101503
    Oct 20101901
    Nov 20102105
    Dec 20101100
    Jan 20111105
    Feb 20111306
    Mar 20112804
    Apr 20111107
    May 2011601
    Jun 20111401
    Jul 2011900
    Aug 20111200
    Sep 2011902
    Oct 2011900
    Nov 20111604
    Dec 2011901
    Jan 2012803
    Feb 20121003
    Mar 20121303
    Apr 2012900
    May 20121909
    Jun 20121500
    Jul 2012900
    Aug 2012800
    Sep 20121100
    Oct 2012702
    Nov 20121305
    Dec 20121007
    Jan 2013900
    Feb 20131000
    Mar 20131206
    Apr 2013701
    May 2013801
    Jun 2013703
    Jul 2013601
    Aug 2013100
    Sep 2013804
    Oct 20131000
    Nov 2013601
    Dec 2013500
    Jan 2014901
    Feb 2014801
    Mar 20142002
    Apr 2014107
    May 2014201
    Jun 2014301
    Jul 2014301
    Aug 2014100
    Sep 20141502
    Oct 20141113
    Nov 2014504
    Dec 20141904
    Jan 2015400
    Feb 2015602
    Mar 2015601
    Apr 2015503
    May 2015503
    Jun 2015301
    Jul 2015200
    Aug 2015301
    Sep 2015600
    Oct 2015401
    Nov 2015102
    Dec 2015501
    Jan 20161001
    Feb 2016401
    Mar 2016500
    Apr 2016800
    May 2016702
    Jun 2016500
    Jul 2016300
    Aug 2016501
    Sep 20161502
    Oct 20161002
    Nov 2016901
    Dec 20161002
    Jan 2017802
    Feb 2017400
    Mar 20171401
    Apr 2017700
    May 2017602
    Jun 2017900
    Jul 2017402
    Aug 2017203
    Sep 20171201
    Oct 20171505
    Nov 20171501
    Dec 20172100
    Jan 2018902
    Feb 20181102
    Mar 2018701
    Apr 20181001
    May 20181102
    Jun 20181400
    Jul 2018300
    Aug 2018301
    Sep 2018602
    Oct 20181604
    Nov 20181202
    Dec 2018300
    Jan 2019600
    Feb 2019500
    Mar 2019500
    Apr 20191900
    May 201910002
    Jun 20192602
    Jul 20193102
    Aug 20194602
    Sep 20193501
    Oct 20194800
    Nov 20197100
    Dec 20195701
    Jan 20205500
    Feb 20206101
    Mar 20204700
    Apr 20206101
    May 20207800
    Jun 20206500
    Jul 20204500
    Aug 20206501
    Sep 20205702
    Oct 20204200
    Nov 20205500
    Dec 20206101
    Jan 20213300

    PreviousNext
    Back to top

    In this issue

    Journal of Pharmacology and Experimental Therapeutics
    Vol. 259, Issue 2
    1 Nov 1991
    • Table of Contents
    • Index by author
    • Back Matter (PDF)
    • Editorial Board (PDF)
    • Front Matter (PDF)
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons.
    (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
    (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Abstract

    Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons.

    G Engberg, T Elebring and H Nissbrandt
    Journal of Pharmacology and Experimental Therapeutics November 1, 1991, 259 (2) 841-847;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Abstract

    Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons.

    G Engberg, T Elebring and H Nissbrandt
    Journal of Pharmacology and Experimental Therapeutics November 1, 1991, 259 (2) 841-847;
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    Similar Articles

    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About JPET
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0103 (Online)

    Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics